Examkin

Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 68-year-old male with highly symptomatic paroxysmal atrial fibrillation is scheduled to begin amiodarone therapy for rhythm control. He has a history of hypertension, type 2 diabetes mellitus, and chronic kidney disease stage 3. His current medications include lisinopril, metformin, and apixaban. He has no history of pulmonary disease. Which of the following baseline laboratory or diagnostic parameters are essential to obtain prior to initiating amiodarone therapy? (Select all that apply)

  1. Thyroid-stimulating hormone levelAnswer
  2. Hepatic transaminasesAnswer
  3. C
    Non-contrast computed tomography of the chest
  4. D
    Prothrombin time and activated partial thromboplastin time
  5. E
    Serum apixaban peak and trough concentrations

Answer

The essential baseline monitoring parameters prior to starting amiodarone are a thyroid-stimulating hormone (TSH) level and hepatic transaminases.
Amiodarone is a highly effective antiarrhythmic agent but is associated with significant long-term toxicities. Because it contains iodine and structurally resembles thyroid hormone, it frequently causes either hypothyroidism or hyperthyroidism; thus, a baseline thyroid-stimulating hormone (TSH) level is mandatory, along with ongoing monitoring. Additionally, amiodarone can cause hepatotoxicity ranging from asymptomatic elevated liver enzymes to severe cirrhosis. Baseline and periodic monitoring of hepatic transaminases is therefore an essential component of patient management when initiating this drug.

Step-by-Step Solution

1
Identify the primary pharmacological agent being initiated and its well-known toxicity profile.
The patient is starting amiodarone, a Class III antiarrhythmic known for multiorgan toxicity, including thyroid, liver, lung, and ocular effects.
Recognizing the adverse effect profile dictates the required baseline screening.
2
Determine the standard baseline testing recommended before starting this medication.
Standard baseline testing includes an ECG, thyroid function tests, liver function tests, and a chest radiograph (often with pulmonary function tests).
Establishing baseline values is critical to detect future organ dysfunction caused by the drug.
3
Evaluate the distractors related to the patient's current medication list, specifically apixaban.
Apixaban does not require routine coagulation monitoring or serum drug level measurements, despite a known pharmacokinetic interaction with amiodarone.
Direct oral anticoagulants have predictable pharmacokinetics and do not require the intensive monitoring seen with warfarin.

Key Concept

Amiodarone requires comprehensive baseline and ongoing monitoring, including thyroid function (TSH) and hepatic transaminases, due to its high risk of multiorgan toxicity.
Rate this question

Topics

Monitoring and Treatment Evaluation

More questions from this topic